New Treatment for Progressive Multiple Sclerosis on the Horizon
4/26/2017 Preliminary study results hint at the possibility for a new type of progressive multiple sclerosis (MS) treatment. Data from the first 6 patients enrolled in the phase 1 study designed to include 10 patients will be presented at the American Academy of ...
No Evidence of Disease Activity Achieved in Multiple Sclerosis with Dimethyl Fumarate
4/26/2017 Post hoc data analysis of the DEFINE and CONFIRM trials showed that a higher percentage of patients with relapsing-remitting multiple sclerosis (RRMS) achieved no evidence of disease activity (NEDA) with delayed-release dimethyl fumarate (DMF) ...
Glove with Sensors Measures Spasticity More Accurately than Physicians
4/26/2017 A multidisciplinary team at the University of California at San Diego has come up with a computerized glove used as a sensor to measure spasticity, or stiffness, in the limbs of patients with multiple sclerosis, cerebral palsy, and stroke. The system ...
New analysis shows emergency hospital admissions for people with Multiple Sclerosis continue to rise
4/26/2017 Emergency hospital admissions for people with Multiple Sclerosis (MS) are on the rise and costing the NHS millions; yet many of them could be avoided, according to a new summary of data by healthcare intelligence provider Wilmington Healthcare and the ...
Latest Tecfidera and Tysabri Data Suggest Treatments Improve MS Outcomes When Used Early
4/26/2017 Real-world data of treatment with Tecfidera (dimethyl fumarate) and Tysabri (natalizumab) in relapsing multiple sclerosis (MS) patients suggest that treatment at early disease stages improves outcomes and prevents disability development.
MS, Wheelchairs, Walkers and Guns: Are They Safe Together?
4/26/2017 When I began writing about multiple sclerosis, I never imagined that, one day, I'd be writing a column about guns. But here I am, staring right into that barrel.
Cheshire event raises $260000 for multiple sclerosis
4/26/2017 Walkers line the side of Route 10 Sunday during the Walk MS fund raiser to help end Multiple Sclerosis atCheshire High School in Cheshire Apr. 23, 2017 | Justin Weekes / For the Record-Journal ...
What the World Is Saying About Ocrevus
4/26/2017 International Multiple Sclerosis Management Practice. “It is like free advertising for Roche stock, and this is at the expense of accurately informing the American public.
Five Towners assist with multiple sclerosis fundraiser
4/26/2017 Mallory and Amara Brenner, mother and daughter, became involved with the Multiple Sclerosis Society after Mallory's brother was diagnosed with the disease that attacks the central nervous system and disrupts the flow of information within the brain and ...
Real-world Data of Gilenya Treatment Validates Slowed Brain Shrinkage as Disease Progression Measure
4/26/2017 A real-world study of Gilenya (fingolimod) in relapsing multiple sclerosis (MS) confirms benefits of the treatment seen in clinical trials.